Marcoux dennis (10 Ergebnisse)

Zustand: New. In English. Rottinger, Amy (illustrator).

Zustand: Good. Volume 155. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,950grams, ISBN:9783540424123.…

gebundene Ausgabe. Zustand: Gut. 500 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber und kann entsprechende Merkmale aufweisen (Rückenschild, Instituts-Stempel.). In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 890.

Soft cover. Zustand: Very Good. No Jacket. 1st Edition. [1st edition], 1st printing ; 216 p. : ill. ; 31 cm. ; ISBN: 0918804183 (pbk.); 9780918804181 (pbk.) LCCN: 83-228212 ; 77-79327 ; LC: NK9612; Dewey: 674/.8 ; OCLC: 10458782 ; "A fine woodworking book" ; "selected by the editors of Fine woodworking magazine." ; photographic stiff paper wrappers ; "Fine Woodworking was launched in 1975 in response to the lack of quality information on the craft. With a circulation of 287,000, it is now the premiere source of how-to information for woodworkers of all skill levels that are seriously interested in woodworking techniques, tools, projects, finishing and design inspiration" ; Contents : Bowls -- Cabinets -- Desks -- Tables -- Beds -- Tools and toys -- Musical instruments -- Furnishings -- Boxes -- Sculpture and carving -- Index -- Directory of woodworkers ; Woodwork artists include Lottie Kwai Lin Wolff, Karlin Wong, Dennis Vidmar, Kenneth Cliet, Alois Von Matt, Steve Voorheis, Jack Voss, David Trapp, Craig Tinker, John Tierney, Howard Werner, Ken Walker, Bradford Walters, Gerald Otis, Takeo Omuro, Will Neptune, Frank Nadell, John Nelson, Joe Nevius, Mike Norby, Kathleen Maiwald, James McEver, Fred MAter, John Marcoux, Alan Marks, Warren May, Michael Kranz, Gordon Kyle -- Bruce Joseph Kunkle, Clement Konzem, Michael Hosaluk, David Holzapfel, Howard Hastings, Greg Harkins, William Hammersley, Joe Hogan, Aleida Iijzerman, Andy Inganni, Bill Irwin, Sata Jaffe, Normand Jussaume, Jon Jennett, Frank Grusauskas, gregory Guenther, Erik Gronberg, David Groth, Louis Gnida, Tom Gannon, Rick Gentle, Grover Floyd, Jack Fenwick, Randall K Fields, Warren Fenzi, David Paul Eck, John Economaki, Bix duPont, John Dunnigan, Rion Dudley, Jeffrey Dale, Ed Dadey, Ron Curtis, Doug Courtney, Clead Christiansen, Jerry Caplan, Christian Brisepierre, Chuck Engberg, Charles Shedden, Edwin Fulwider etc ; ownership stamp ; cover a little dusty, else VG. Book.…

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 524 | Sprache: Englisch | Produktart: Bücher | "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis­ ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri­ bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro­ logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.…

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 528 | Sprache: Englisch | Produktart: Bücher | "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis­ ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri­ bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro­ logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.…

Zustand: New. In English.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - 'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - 'CNS neuroprotection' was a common subject of papers, symposia, and reviews during the previous 'decade of the brain. ' Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, 'Mechanistic Approaches to CNS Neuroprotection,' reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.…

Hardcover. Zustand: Brand New. 500 pages. 9.75x6.50x1.00 inches. In Stock.